This fund manager likes these 3 stocks: Should you buy?

Head of Australian Equities at fund management firm T Rowe Price gives a little insight into what stocks to follow.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Wouldn't you love to peek over the shoulder of a professional investor and find out what they think are great stocks?

Recently, the Head of Australian Equities for fund management firm T Rowe Price, Randall Jenneke, told Fairfax Media three stocks that he thought have attractive potential. Firstly, companies that generate a greater proportion of revenue overseas will have an advantage in a weaker Aussie dollar environment.

Just last week, the US Federal Reserve stopped its quantitative easing (QE) and the US dollar has bumped up in strength. Conversely, that sent the Aussie down.

Jenneke suggested these three companies:

1) Amcor Limited (ASX: AMC), the global packaging giant gets only 17% of its revenue from Australia. It had a bumper year in FY 2014, thanks to demerging from Orora Ltd (ASX: ORA) and growth from acquisitions. It yields 3.8% unfranked and is priced at 16 times earnings.

2) Ansell Limited (ASX: ANN) is the market leader in plastic gloves and other protective wear which investors can find in hospitals and food service companies. It has about 84% of revenue coming from overseas. Over the next two years, consensus forecasts are for earnings to grow double digits in the mid-teens. It pays a 2.2% yield unfranked.

The sector that he is really bullish on is fertility clinics. Privately, they have been around for years, but recently several have listed on the ASX. More people are having difficulty with bearing children and specialised services like these can do good business. Here's one that Jenneke's investment firm bought at the IPO stage.

Virtus Health Ltd (ASX: VRT) provides assisted reproduction services. Since listing in June 2013, the stock is up about 23%. Net profit was up greatly from FY 2013 and it's expected to grow earnings around 19% annually over the next two years. It looks very promising and has a 3.6% fully franked dividend, so I'll need to watch this new stock myself. Add it to your watchlist if not to your portfolio.

Motley Fool contributor Darryl Daté-Shappard does not own shares in any company mentioned. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »